## Analysis of Congeneric Series for m05

### Congener Identification
Molecule m05 (COc1ccc(cc1)C(=O)NCCCCCCCCCCC) belongs to a series with the core scaffold:
COc1ccc(cc1)C(=O)N followed by variable alkyl chain lengths.

Identified congeners in the pool:
- m15: COc1ccc(cc1)C(=O)NCC (2 carbon chain) - QED: 0.7621
- m24: COc1ccc(cc1)C(=O)NCCC (3 carbon chain) - QED: 0.7919
- m28: COc1ccc(cc1)C(=O)NCCCC (4 carbon chain) - QED: 0.7518
- m17: COc1ccc(cc1)C(=O)NCCCCC (5 carbon chain) - QED: 0.7498
- m22: COc1ccc(cc1)C(=O)NCCCCCC (6 carbon chain) - QED: 0.7377

### Trend Analysis
The QED vs. chain length relationship shows a non-linear pattern:
- Initially increasing from 2C (0.7621) to 3C (0.7919)
- Then decreasing as chain length increases further: 4C (0.7518), 5C (0.7498), 6C (0.7377)

This suggests an optimal chain length around 3 carbon atoms, with QED decreasing as the chain becomes longer due to increased lipophilicity and reduced drug-likeness.

### Prediction for m05
M05 has 11 carbon atoms in the N-alkyl chain, significantly longer than the measured range (2-6). Extrapolating the decreasing trend from 3C-6C, the QED for m05 is estimated to be around 0.64-0.66. The relationship is likely exponential decay rather than linear, so the actual value may be somewhat lower than a simple linear extrapolation would suggest.

### Lead Compound Selection
To satisfy all three constraints:
1. Measured QED ≥ 0.6
2. PSA ≥ 40
3. Not in the same series as m05

I evaluated molecules with PSA ≥ 40 that are not in the methoxyphenyl series:
- Trihydroxyalkyl series molecules (PSA = 110.02): m01, m03, m14, m19 - all had QED < 0.6
- Nitrophenyl series molecules (PSA = 72.24): m02 - had QED = 0.6046

Molecule m02 (O=[N+]([O-])c1ccc(cc1)C(=O)NCCC) meets all criteria:
- QED = 0.6046 (≥ 0.6) ✓
- PSA = 72.24 (≥ 40) ✓
- Different series from m05 ✓